Reach Us +1-218-451-2974


Satoshi Yamaguchi | OMICS International
ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google scholar citation report
Citations : 2275

Journal of Alzheimers Disease & Parkinsonism received 2275 citations as per google scholar report

Journal of Alzheimers Disease & Parkinsonism peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Satoshi Yamaguchi

Department of Geriatric Behavioral Neurology, Tohoku University CYRIC, Sendai, Japan


Dr. Satoshi Yamaguchi is a versatile writer and scientist that published extensively in Geriatric Neurology, Geriatric Behavioral Neurology and Prevalence. She is currently working at Tohoku University CYRIC, Japan.

Lifetime Expectancy in Dementia with Lewy Bodies: Effects of Donepezil Administration and Special Nursing Home Replacement. A Retrospective Analysis in the Tajiri Project

Objective: Cholinesterase inhibitors (ChEIs) can delay the progression of Alzheimer disease (AD). We previously demonstrated a positive effect of donepezil (DNP) administration and a Special Nursing Home (SNH) replacement on lifetime expectancy after the onset of AD. Recently DNP has been indicated for use in the treatment of dementia with Lewy Bod... Read More»

Kenichi Meguro, Keiichi Kumai, Junko Takada, Keiko Chida, Yuriko Kato and Satoshi Yamaguchi

Research Article: J Alzheimers Dis Parkinsonism 2018, 8:416

DOI: 10.4172/2161-0460.1000416

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article